Casabonne, Delphine
Gracia, Esther
Espinosa, Ana
Bustamante, Mariona
Benavente, Yolanda
Robles, Claudia
Costas, Laura
Alonso, Esther
Gonzalez-Barca, Eva
Tardón, Adonina
Dierssen-Sotos, Trinidad
Vázquez, Eva Gimeno
Aymerich, Marta
Campo, Elies
Jiménez-Moleón, José J.
Marcos-Gragera, Rafael
Castaño-Vinyals, Gemma
Aragones, Nuria
Pollan, Marina
Kogevinas, Manolis
Urtiaga, Carmen
Amiano, Pilar
Moreno, Victor
de Sanjose, Silvia
Funding for this research was provided by:
Instituto de Salud Carlos III (grants PI08/1770, RD09/0076/00036, RTIC RD12/0036/0036, PI08/0533, PI08/1359, PS09/00773-Cantabria, PI11/01810, PI11/02213, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RTIC RD12/0036/0056, Rio Hortega CM13/00232, SV-09-CLINIC-1, MINECO and CIBERESP)
the Fundación Marques de Valdecilla (API 10/09)
Obra Social CAJASTUR (SV-CAJASTUR-1)
Recercaixa (2010ACUP 00310)
the Spanish Association Against Cancer (AECC) Scientific Foundation
the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR)–Generalitat de Catalunya (Catalonian Government) (2009SGR1026, 2014SGR756 and 2009SGR1465)
Pla Director d’Oncologia de Catalunya (XBTC).